Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma

Journal of Clinical Pathology

Volumn 57, Issue 6, 2004, Pages 630-636

  Esposito, I ^a   Menicagli, M ^b   Funel, N ^b   Bergmann, F ^a   Boggi, U ^b   Mosca, F ^b   Bevilacqua, G ^b   Campani, D ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BIOCHEMICAL MARKER; VASCULOTROPIN A; VASCULOTROPIN C;

ADULT; AGED; ARTICLE; CANCER CELL; CELL COUNT; CELL INFILTRATION; CHRONIC PANCREATITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LYMPH NODE METASTASIS; MACROPHAGE; MALE; MAST CELL; MICROVASCULATURE; PANCREAS ADENOCARCINOMA; PARENCHYMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; INFLAMMATION; LYMPHATIC METASTASIS; MACROPHAGES; MALE; MAST CELLS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PANCREAS; PANCREATIC NEOPLASMS; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 2642547301     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2003.014498     Document Type: Article

References (52)

1. Solcia E, Capella G, Klöppel G. Tumors of the exocrine pancreas. In: Rosai J, Sobin L, eds. Atlas of tumor pathology. Tumors of the pancreas. Washington DC: Armed Forces Institute of Pathology, 1997:64-88.
2. Ryu B, Jones J, Hollingsworth MA, et al. Invasion-specific genes in malignancy: serial analysis of gene expression comparisons of primary and passaged cancers. Cancer Res 2001;61:1833-8.
3. Iacobuzio-Donahue CA, Ryu B, Hruban RH, et al. Exploring the host desmoplastic response to pancreatic carcinoma: gene expression of stromal and neoplastic cells at the site of primary invasion. Am J Pathol 2002;160:91-9.
4. Gouon-Evans V, Lin EY, Pollard JW. Requirement of macrophages and easinophils and their cytokines/chemokines for mammary gland development. Breast Cancer Res 2002;4:155-64.
5. Wong YC, Wang YZ. Growth factors and epithelial-stromal interactions in prostate cancer development. Int Rev Cytol 2000;199:65-116.
6. Farrow B, Evers BM. Inflammation and the development of pancreatic cancer. Surg Oncol 2002;10:153-69.
7. Esposito I, Friess H, Buchler MW. Molecular mechanisms in chronic pancreatitis. Zentralbl Chir 2001;126:867-72.
8. Balaz P, Friess H, Buchler MW. Growth factors in pancreatic health and disease. Pancreatology 2001;1:343-55.
9. Kleeff J, Kusama T, Rossi DL, et al. Detection and localization of Mip-3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer. Int J Cancer 1999;81:650-7.
10. Lin EY, Nguyen AV, Russell RG, et al. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 2001;193:727-40.
11. Westphal E. Über Mastzellen. Histologie und Klinik des Plutes: gesammelte Mitt(h)eilungen. In: Ehrlich P, ed. Farbenanalytische Untersuchungen. Zur Berlin: Hirschwald Press, 1891:17-21.
12. Ribatti D, Ennas MG, Vacca A, et al. Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma. Eur J Clin Invest 2003;33:420-5.
13. Takanami I, Takeuchi K, Naruke M. Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma. Cancer 2000;88:2686-92.
14. Elpek GO, Gelen T, Aksoy NH, et al. The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus. J Clin Pathol 2001;54:940-4.
15. Esposito I, Kleeff J, Bischoff SC, et al. The stem cell factor-c-kit system and mast cells in human pancreatic cancer. Lab Invest 2002;82:1481-92.
16. Klöppel G, Hruban R, Adler G, et al. Tumours of the exocrine pancreas. In: Hamilton S, Aaltonen L, eds. World Health Organisation classification of tumours. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press, 2000:220-30.
17. Sobin L, Wittekind C. TNM classification of malignant tumours, 6th ed. New York: Wiley-Liss, Inc, 2002.
18. Ochsenbein AF. Principles of tumor immunosurveillance and implications for immunotherapy. Cancer Gene Ther 2002;9:1043-55.
19. Dunn GP, Bruce AT, Ikeda H, et al. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 2002;3:991-8.
20. Ribatti D, Vacca A, Nico B, et al. The role of mast cells in tumour angiogenesis. Br J Haematol 2001;115:514-21.
21. Bingle L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 2002;196:254-65.
22. Fujiaka S, Yoshida K, Yanagisawa S, et al. Angiogenesis in pancreatic carcinoma: thymidine phosphorylase expression in stromal cells and intratumoral microvessel density as independent predictors of overall and relapse-free survival. Cancer 2001;92:1788-97.
23. Tang RF, Itakura J, Aikawa T, et al. Overexpression of lymphangiogenic growth factor VEGF-C in human pancreatic cancer. Pancreas 2001;22:285-92.
24. Itakura J, Ishiwata T, Friess H, et al. Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression. Clin Cancer Res 1997;3:1309-16.
25. Yamanaka Y, Friess H, Buchler M, et al. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res 1993;53:5289-96.
26. Fujimoto K, Hosotani R, Wada M, et al. Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, and its relationship to angiogenesis. Eur J Cancer 1998;34:1439-47.
27. Jones M, Tussey L, Athanasou N, et al. Heparan sulfate proteaglycan isoforms of the CD44 hyaluronan receptor induced in human inflammatory macrophages can function as paracrine regulators of fibroblast growth factor action. J Biol Chem 2000;275:7964-74.
28. Akimoto S, Ishikawa O, Iijima C, et al. Expression of basic fibroblast growth factor and its receptor by fibroblasts, macrophages and mast cells in hypertrophic scar. Eur J Dermatol 1999;9:357-62.
29. Gruber BL, Marchese MJ, Kew R. Angiogenic factors stimulate mast-cell migration. Blood 1995;86:2488-93.
30. Skobe M, Homberg LM, Hawighorst T, et al. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am J Pathol 2001;159:893-903.
31. Imada A, Shijubo N, Kojima H, et al. Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma. Eur Respir J 2000;15:1087-93.
32. Ohta M, Kitadai Y, Tanaka S, et al. Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas. Int J Cancer 2002;102:220-4.
33. Barbera-Guillem E, Nyhus JK, Wolford CC, et al. Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process. Cancer Res 2002;62:7042-9.
34. Moller A, Lippert U, Lessmann D, et al. Human mast cells produce IL-8. J Immunol 1993;151:3261-6.
35. Grutzkau A, Kruger-Krasagakes S, Baumeister H, et al. Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. Mol Biol Cell 1998;9:875-84.
36. Leibovich SJ, Polverini PJ, Shepard HM, et al. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 1987;329:630-2.
37. Chen JJ, Yao PL, Yuan A, et al. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. Clin Cancer Res 2003;9:729-37.
38. Yana H, Kinuta M, Tateishi H, et al. Mast cell infiltration around gastric cancer cells correlates with tumor angiogenesis and metastasis. Gastric Cancer 1999;2:26-32.
39. Benitez-Bribiesca L, Wong A, Utrera D, et al. The role of mast cell tryptase in neoangiogenesis of premalignant and malignant lesions of the uterine cervix. J Histochem Cytochem 2001;49:1061-2.
40. Tanaka Y, Kobayashi H, Suzuki M, et al. Thymidine phosphorylase expression in tumor-infiltrating macrophages may be correlated with poor prognosis in uterine endometrial cancer. Hum Pathol 2002;33:1105-13.
41. Valkovic T, Dobrila F, Melato M, et al. Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma. Virchows Arch 2002;440:583-8.
42. Esposito I, Friess H, Kappeler A, et al. Mast cell distribution and activation in chronic pancreatitis. Hum Pathol 2001;32:1174-83.
43. Taipale J, Lohi J, Saarinen J, et al. Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial and endothelial cells. J Biol Chem 1995;270:4689-96.
44. Muramatsu M, Katada J, Hattori M, et al. Chymase mediates mast cell-induced angiogenesis in hamster sponge granulomas. Eur J Pharmacol 2000;402:181-91.
45. Blair RJ, Meng H, Marchese MJ, et al. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J Clin Invest 1997;99:2691-700.
46. Ikeda N, Adachi M, Taki T, et al. Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer 1999;79:1553-63.
47. Linder S, Blasjo M, van Rosen A, et al. Pattern of distribution and prognostic value of angiogenesis in pancreatic duct carcinoma: a semiquantitative immunohistochemical study of 45 patients. Pancreas 2001;22:240-7.
48. Khan AW, Dhillon AP, Hutchins R, et al. Prognostic significance of intratumoural microvessel density (IMD) in resected pancreatic and ampullary cancers to standard histopathological variables and survival. Eur J Surg Oncol 2002;28:637-44.
49. McKenna S, Eatock M. The medical management of pancreatic cancer: a review. Oncologist 2003;8:149-60.
50. Rosenberg L, Lipsett M. Biotherapeutic approaches to pancreatic cancer. Expert Opin Biol Ther 2003;3:319-37.
51. Schoppmann SF, Birner P, Stockl J, et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 2002;161:947-56.
52. Skobe M, Hawighorst T, Jackson DG, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001;7:192-8.